Impaired fibrinolysis and lower levels of plasma α2-macroglobulin are associated with an increased risk of severe asthma exacerbations

[1]  L. Mastalerz,et al.  Prothrombotic State in Asthma Is Related to Increased Levels of Inflammatory Cytokines, IL-6 and TNFα, in Peripheral Blood , 2017, Inflammation.

[2]  Meilan K. Han,et al.  Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts , 2017, American journal of respiratory and critical care medicine.

[3]  M. Tomasiak,et al.  Asthma is associated with reduced fibrinolytic activity, abnormal clot architecture, and decreased clot retraction rate , 2017, Allergy.

[4]  L. Mastalerz,et al.  Asthma is associated with enhanced thrombin formation and impaired fibrinolysis , 2016, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[5]  T. van der Poll,et al.  UvA-DARE ( Digital Academic Repository ) Asthma and coagulation : A clinical and pathophysiological evaluation , 2016 .

[6]  R. Wagenvoord,et al.  The balance of pro‐ and anticoagulant processes underlying thrombin generation , 2015, Journal of thrombosis and haemostasis : JTH.

[7]  徐武輝,et al.  Increased stroke risk among adult asthmatic patients , 2014 .

[8]  P. Kyrle.  Venous thrombosis: who should be screened for thrombophilia in 2014? , 2013, Polskie Archiwum Medycyny Wewnetrznej.

[9]  F. Ho,et al.  Asthma increases pulmonary thromboembolism risk: a nationwide population cohort study , 2013, European Respiratory Journal.

[10]  A. Zwinderman,et al.  Risk of deep vein thrombosis and pulmonary embolism in asthma , 2012, European Respiratory Journal.

[11]  T. van der Poll,et al.  Asthma and coagulation. , 2012, Blood.

[12]  Jeroen J. Bax,et al.  ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation , 2012 .

[13]  J. Zalewski,et al.  A history of early stent thrombosis is associated with prolonged clot lysis time , 2012, Thrombosis and Haemostasis.

[14]  Jeroen J. Bax,et al.  2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). , 2011, European heart journal.

[15]  Anetta Undas,et al.  Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases. , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[16]  T. Lauer,et al.  Kardiologische Aspekte der präoperativen Risikostratifizierung , 2011 .

[17]  K. Preissner,et al.  Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases , 2010, Nature Medicine.

[18]  F. Rosendaal,et al.  The impact of the fibrinolytic system on the risk of venous and arterial thrombosis. , 2009, Seminars in thrombosis and hemostasis.

[19]  I. Pavord,et al.  An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. , 2009, American journal of respiratory and critical care medicine.

[20]  J. Fahy,et al.  Acute exacerbations of asthma: epidemiology, biology and the exacerbation‐prone phenotype , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[21]  T. Lasserson,et al.  Combination formoterol and inhaled steroid versus beta2-agonist as relief medication for chronic asthma in adults and children. , 2009, The Cochrane database of systematic reviews.

[22]  Fernando Holguin,et al.  Relation of adult-onset asthma to coronary heart disease and stroke. , 2008, The American journal of cardiology.

[23]  P. Monagle,et al.  Thrombin generation: the functional role of alpha‐2‐macroglobulin and influence of developmental haemostasis , 2007, British journal of haematology.

[24]  A. Chu.  Tissue factor mediates inflammation. , 2005, Archives of biochemistry and biophysics.

[25]  W. Busse,et al.  The role of rhinovirus in asthma exacerbations. , 2005, The Journal of allergy and clinical immunology.

[26]  G. Laurent,et al.  Shooting for PARs in lung diseases. , 2004, Current opinion in pharmacology.

[27]  Tatsuya Hayashi,et al.  Thrombin stimulates the expression of PDGF in lung epithelial cells. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[28]  W. Borth.  α2“Macroglobulin, a multifunctional binding protein with targeting characteristics , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  L. Sottrup-jensen.  Alpha-macroglobulins: structure, shape, and mechanism of proteinase complex formation. , 1989, The Journal of biological chemistry.

[30]  C. Brightling,et al.  Severe asthma: novel advances in the pathogenesis and therapy. , 2014, Polskie Archiwum Medycyny Wewnetrznej.

[31]  H. Hemker,et al.  Data management in thrombin generation. , 2013, Thrombosis research.

[32]  H. Hemker,et al.  Thrombin generation, a function test of the haemostaticthrombotic system , 2006, Thrombosis and Haemostasis.

[33]  D. Rość,et al.  Fibrinolysis system in patients with bronchial asthma. , 2000, Medical science monitor : international medical journal of experimental and clinical research.

[34]  S. Hatano,et al.  Experience from a multicentre stroke register: a preliminary report. , 1976, Bulletin of the World Health Organization.

[35]  M. Sherman,et al.  A Preliminary Report , 1953 .